-
公开(公告)号:ES2143122T3
公开(公告)日:2000-05-01
申请号:ES96116938
申请日:1996-10-22
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , BRENDEL JOACHIM DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR , LANG HANS JOCHEN DR , ALBUS UDO DR
IPC: A61K31/165 , A61K31/18 , A61P1/16 , A61P3/08 , A61P9/04 , A61P9/08 , A61P9/10 , A61P11/00 , A61P13/02 , A61P15/00 , A61P35/00 , A61P41/00 , A61P43/00 , C07C279/18 , C07C313/02 , C07C313/06 , C07C381/10
Abstract: Sulphonimidamides of formula R1N=S(O)(R2)N(R4)(R3) (I) and their salts are new: at least one of R1-R3 = a benzoylguanidine group of formula (a) optionally substituted in the phenyl ring by 1-4 of 1-8C alkyl, 2-8C alkenyl, (CH2)mR14, halo, CN, CF3, R22SO2, R23R24NCO, R25CO, R26R27NSO2, OR35, SR35 or NR35R36; m = 0-2; R14 = 3-8C cycloalkyl, phenyl optionally substituted by 1-3 of F, Cl, CF3, Me, OMe or NR15R16; R15, R16 = H or Me; R22, R23, R25, R26 = 1-8C alkyl, 2-8C alkenyl, (CH2)nR29 or CF3; or R23+R24, R26+R27 = 5-6 methylene groups with optionally one CH2 replaced by O, S, NH, NMe or N-benzyl; or R23, R25, R26 = H; n = 0-4; R29 = 3-7C cycloalkyl, phenyl optionally substituted by 1-3 of F, Cl, CF3, Me, OMe or NR30R31; R30, R31 = H or 1-4C alkyl; R24, R27 = H or 1-4C alkyl; R35, R36 = H or 1-6C alkyl; or R35+R36 = 4-7 methylene groups with optionally one CH2 replaced by O, S, NH, NMe or N-benzyl; or R35 = phenyl optionally substituted by 1-3 of F, Cl, CF3, Me, OMe, SO2R5, SO2NR6R7 or NR32R33; R5 = 1-6C alkyl; R6, R7 = H or 1-4C alkyl; R32, R33 = H or 1-4C alkyl; or R35 = 1-9C heteroaryl optionally substituted by 1-3 of F, Cl, CF3, CH3, OMe, OH, NH2, NHMe or N(Me)2; the remaining R1-R3 = 1-8C alkyl or (CH2)pR10; or the remaining R1, R2 = H; p = 0-4; R10 = phenyl optionally substituted by 1-3 of F, Cl, CF3, Me, OMe, SO2NR17R8 or SO2R9; R17, R8 = H or 1-4C alkyl; R9 = 1-4C alkyl; and R4 = H or 1-4C alkyl.
-
公开(公告)号:GR3032221T3
公开(公告)日:2000-04-27
申请号:GR990403308
申请日:1999-12-22
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: C07D295/12 , A61K31/155 , A61K31/18 , A61K31/395 , A61K31/40 , A61K31/415 , A61K31/4166 , A61K31/4184 , A61K31/47 , A61K31/495 , A61K31/496 , A61K31/535 , A61K31/5355 , A61K31/5375 , A61P1/16 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/00 , A61P13/08 , A61P13/12 , A61P35/00 , C07C279/22 , C07C311/15 , C07C311/18 , C07C311/29 , C07C311/64 , C07C317/28 , C07C317/46 , C07C323/16 , C07C323/25 , C07C335/32 , C07C381/10 , C07D207/09 , C07D213/40 , C07D213/70 , C07D215/36 , C07D233/42 , C07D233/54 , C07D233/60 , C07D233/84 , C07D235/28 , C07D295/22 , C07D521/00
Abstract: Basic substd. benzoylguanidine derivs. of formula (I) and their salts are new. One of R1-R3 = Xf-CdH2d-B-A-R6 and the others of R1-R3 = H, F, Cl, Br, I, CN, 1-8C alkyl, 2-8C alkenyl, NR35R36 or Zh-CgH2g-R17; R6 = NR7R8, C(=NR9)NR7R8, NR10-C(=NR9)NR7R8 or basic heteroaromatic ring system with 1-9C; R7-R10 = H or 1-4C alkyl; or R7+R8 = C4H8 or CaH2a (opt. with one CH2 replaced by O, S(O)m or NR11; or R8+R9+R10 or R7+R10 = C2H4 or CcH2c (opt. with one CH2 replaced by O, S(O)m or NR11); A = CbH2b (opt. with one or two CH2 replaced by O, CO, CH(OR20), S(O)m, NR20, CONR20, NHCONR20, SO2NHCONR20, S(=O)(=NR19)NR20 or SO2NR20, or one CH2 replaced by CHR99); R7+R99 form pyrrolidine or piperidine; B = opt. substd. phenylene or naphthylene gp. of formula (i) or (ii); R12, R13 = H, Me, F, Cl, Br, I, CF3 or S(O)mR14; R14, R19 = H or 1-4C alkyl; X = O, CO, CH(OR21), SOm or NR21; R35, R36 = H or 1-6C alkyl; or R35+R36 = (CH2)4-7, with one CH2 opt. replaced by S, NH, NMe or N-benzyl; Z = O, CO, SOm, NR18, CONR18, NHCONR18 or SO2NR18; R17 = H, cyclopropyl, cyclopentyl, cyclohexyl, 1-3C perfluoroalkyl, 1-, 2- or 3-pyrrolyl (opt. substd. by 1-4 of F, Cl, Br, I, CN, 2-8C alkanoyl, 2-8C alkoxycarbonyl, CHO, COOH, CF3, Me and OMe) or 3-8C cycloalkyl or phenyl (both opt. substd. by 1-3 of F, Cl, CF3, Me, OH, OMe, NR37R38, SO2Me and SO2NH2); R11, R18, R20, R21, R37, R38 = H or Me; R4, R5 = H, 1-4C alkyl, F, Cl, OR32, NR33R34 or 1-4C perfluoroalkyl; R32-R34 = H or 1-3C alkyl; a = 5-7; b = 1-10; c = 3-5; d = 0-5; g = 0-4; f, h = 0 or 1; m = 0-2.
-
公开(公告)号:SI0791577T1
公开(公告)日:2000-02-29
申请号:SI9730024
申请日:1997-01-20
Applicant: HOECHST AG
Inventor: ALBUS UDO DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS JOCHEN DR , SCHOLZ WOLFGANG DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR
IPC: A61K31/165 , A61K31/155 , A61P1/16 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P13/02 , A61P15/00 , A61P35/00 , A61P43/00 , C07C279/10 , C07C279/20 , C07C279/22
Abstract: Ortho-substituted benzoylguanidines of formula (I) and their salts are new: R2, R3 = H, Cl, Br, I, 1-8C alkyl, 3-8C cycloalkyl or OR5; provided that one, but not both of R2 or R3 = H; R5 = 1-8C alkyl, or CdH2d-(3-8C cycloalkyl); and d = 0-2.
-
公开(公告)号:GR3031111T3
公开(公告)日:1999-12-31
申请号:GR990402193
申请日:1999-08-31
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A61K31/155 , A61K31/166 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/4418 , A61K31/165 , A61P9/00 , A61P9/06 , A61P9/10 , A61P43/00 , C07C277/08 , C07C279/22 , C07C311/15 , C07C317/32 , C07C317/44 , C07C317/48 , C07C323/62 , C07D207/337 , C07D213/30 , C07D213/53 , C07D213/54 , C07D213/58 , C07D213/65 , C07D215/14 , C07D217/16 , C07D231/12 , C07D233/06 , C07D233/61 , C07D233/64 , C07D241/26 , C07D241/28
Abstract: There are described benzoylguanidines of the formula I in which: R(1) is R(6)-CO or R(7)R(8)N-CO, where R(6), R(7) and R(8) are (perfluoro)alk(en)yl, -(CH)2n-R(9), R(9) is cycloalkyl, phenyl, biphenylyl or naphthyl, where R(7) and R(8) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; R(2) is defined as R(1), or is H, Hal, CN, NO2, (perfluoro)alk(en)yl, -(CH)2 R(15) where R(15) is cycloalkyl, phenyl, biphenylyl or naphthyl, or R(2) is (C1-C9)-heteroaryl, or R(2) is SR(18), -OR(18), -NR(18)R(19), -CR(18)R(19)R(20); R(18) = -(CH2)-heteroaryl, R(19), R(20) are defined as R(18) or are H, (perfluoro)-alkyl, or R(2) is R(21)-SOm or R(22)R(23)N-SO2-, where R(21) is (perfluoro)alk(en)yl, -CH2-R(24), R(24) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(22) is H, (perfluoro)alk(en)yl, -(CH2)n-R(29), R(29) is (C3-C8)-cycloalkyl, phenyl, biphenylyl or naphthyl, R(23) is H, (perfluoro)alkyl, where R(22) and R(23) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; or R(33)X-, where R(2) is X is oxygen, S, NR(34), (D=O)A-, NR(34)C=MN R(35)-, where M is oxygen, S, A = oxygen, NR(34), D = C, SO R(33) and R(35) are (perfluoro)alk(en)yl, -(CH2)n-R(36), where R(36) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(34) = H, (perfluoro)alkyl, where A and N are bonded to the phenyl ring of the benzoylguanidine parent structure; or R(2) is -SR(40), -OR(40), -NHR(40)R(41), -CHR(40)R(42), -C=CR(45) where R(40), R(41) are identical or different, and are -(CH2)p-(CHOH)q-(CH2)r-(CHOH)t-R(51) or -(CH2)p-O-(CH2-CH2O)q-R(51), R(51) is hydrogen or methyl, R(42), R(43) are hydrogen or alkyl or, together with the carbon atom carrying them, form a (C3-C8)-cycloalkyl; R(44) is H, (C1-C6)-alkyl, (C3-C8)-cycloalkyl, -CeH2e-R(45) where R(45) is phenyl, heteroaryl or alkyl, R(46), R(47), R(48), R(49) and R(50) are hydrogen or methyl; or R(2) is R(55)-NH-SO2-, R(3), R(4) and R(5) are independently of one another defined as R(1) or R(2); and their pharmaceutically tolerable salts.0
-
公开(公告)号:DK0682017T3
公开(公告)日:1999-12-13
申请号:DK95106596
申请日:1995-05-02
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A61K31/165 , A61K31/47 , A61K31/472 , A61P3/08 , A61P3/10 , A61P9/06 , A61P9/10 , A61P13/08 , A61P35/00 , A61P43/00 , C07C279/22 , C07D215/00 , C07D215/48 , C07D215/54 , C07D215/56 , C07D217/00 , C07D217/02 , C07D217/26
Abstract: New bicyclic heteroaryl-carboxy-guanidine cpds. and their salts have two fused 6-membered rings contg. up to 4 unsubstd. ring N atoms. The other ring members are C atoms, opt. substd. e.g. by halo, alkyl, alkoxy, alkenyl, alkynyl, amino, carboxyguanidine, cyano, alkylthio, acyl, carboxamido, perfluoroalkyl, (poly)hydroxyalkyl, alkanoylalkyl, aminosulphonyl, (thio)ureidosulphonyl, heteroaryl, phenoxy, phenylthio or phenylamino, where the phenyl rings are opt. substd. by heterocyclyl, (poly)hydroxyalkyl or (poly)hydroxyalkylcarbonyl; or two substits. together form a satd. gp. that completes a fused ring.
-
公开(公告)号:DK0700899T3
公开(公告)日:1999-10-18
申请号:DK95113847
申请日:1995-09-04
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR , WEICHERT ANDREAS DR , LANG HANS-JOCHEN DR , KLEEMANN HEINZ-WERNER DR
IPC: A61K31/165 , A61K31/155 , A61K31/18 , A61K31/27 , A61K31/275 , A61P3/08 , A61P3/10 , A61P3/12 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/00 , A61P25/02 , A61P25/28 , A61P35/00 , A61P41/00 , A61P43/00 , C07C229/00 , C07C277/08 , C07C279/22 , C07C317/46 , C07C323/44 , C07C323/60 , C07C323/63
Abstract: Benzoyl guanine derivs. of formula(I) and their salts are new. One of the substits. R1-R3 = Y-Ph-Ä(CH2)k-CHR7-CO-R8Ü; and the others = 1-8C alkyl, 2-8C alkenyl, (CH2)mR14, SO2NHC(=Y')NR18R19, H, halo, CN, Z(CH2)p-CqF2q+1, SOuR22, CONR23R24, COR25, SO2NR26R27, OR35 or NR35R36; Ph = phenylene (opt. mono- or di-substd. by Fl, Cl, CF3, Me, OH, OMe or NR37R38); R37, R38 = H or Me; Y = a bond, O, S or NR9; R9 = H or 1-4C alkyl; R7 = OR10 or NR10R11; R10 = H 1-8C alkyl, 1-8C alkanoyl, 1-8C alkoxycarbonyl, benzyl, or benzyloxycarbonyl; R11 = as R10 or trityl; R8 = OR12 or NR12R13; R12, R13 = H, 1-8C alkyl or benzyl; R14 = 3-8C cycloalkyl or phenyl (both opt. substd. by 1-3 F, Cl, CF3, Me, OMe, or NR15R16); R15, R16 = H or Me; Y' = O, S or NR20; R18, R19 = H, 1-8C alkyl, 3-6C alkenyl or (CH2)tR21; or R18+R19 = A; R21 = 5-7C cycloalkyl or phenyl, (both opt. mono- to tri-substd. by F, Cl, OMe or 1-4C alkyl); R20 = as R18 or amidine; Z = a bond, O, S or NR28; R22 = 1-8C alkyl, 3-6C alkenyl, (CH2)nR29 or CF3; R23, R25, R26 = as R22 or H; R24, R27 = H or 1-4C alkyl; or R23+R24, R26+R27 = A; A = (CH2)4 or (CH2)5 (both opt. having a CH2 replaced by O, S, NH, NMe or N-benzyl; R28 = H or 1-3C alkyl; R29 = 3-7C cycloalkyl or phenyl (both opt. substd. by 1-3 F, Cl, CF3, Me, OMe or NR30R31; R30, R31 = H or 1-4C alkyl; R35, R36 = H or 1-6C alkyl; or R35+R36 = (CH2)y (opt. having a CH2 gp. replaced by O, S, NH, NMe or N-benzyl); R4, R5 = H, 1-4C alkyl, F, Cl, OR32, NR33R34 or CrF2r+1; R32-R34 = H or 1-3C alkyl; k, n, t = 0-4; m, u, p = 0-2; q = 1-6; r = 1-4; and y = 4-7.
-
公开(公告)号:ES2134878T3
公开(公告)日:1999-10-16
申请号:ES94108280
申请日:1994-05-30
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A61K31/165 , A61K31/155 , A61K31/166 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/4418 , A61P9/00 , A61P9/06 , A61P9/10 , A61P43/00 , C07C277/08 , C07C279/22 , C07C311/15 , C07C317/32 , C07C317/44 , C07C317/48 , C07C323/62 , C07D207/337 , C07D213/30 , C07D213/53 , C07D213/54 , C07D213/58 , C07D213/65 , C07D215/14 , C07D217/16 , C07D231/12 , C07D233/06 , C07D233/61 , C07D233/64 , C07D241/26 , C07D241/28
Abstract: There are described benzoylguanidines of the formula I in which: R(1) is R(6)-CO or R(7)R(8)N-CO, where R(6), R(7) and R(8) are (perfluoro)alk(en)yl, -(CH)2n-R(9), R(9) is cycloalkyl, phenyl, biphenylyl or naphthyl, where R(7) and R(8) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; R(2) is defined as R(1), or is H, Hal, CN, NO2, (perfluoro)alk(en)yl, -(CH)2 R(15) where R(15) is cycloalkyl, phenyl, biphenylyl or naphthyl, or R(2) is (C1-C9)-heteroaryl, or R(2) is SR(18), -OR(18), -NR(18)R(19), -CR(18)R(19)R(20); R(18) = -(CH2)-heteroaryl, R(19), R(20) are defined as R(18) or are H, (perfluoro)-alkyl, or R(2) is R(21)-SOm or R(22)R(23)N-SO2-, where R(21) is (perfluoro)alk(en)yl, -CH2-R(24), R(24) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(22) is H, (perfluoro)alk(en)yl, -(CH2)n-R(29), R(29) is (C3-C8)-cycloalkyl, phenyl, biphenylyl or naphthyl, R(23) is H, (perfluoro)alkyl, where R(22) and R(23) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; or R(33)X-, where R(2) is X is oxygen, S, NR(34), (D=O)A-, NR(34)C=MN R(35)-, where M is oxygen, S, A = oxygen, NR(34), D = C, SO R(33) and R(35) are (perfluoro)alk(en)yl, -(CH2)n-R(36), where R(36) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(34) = H, (perfluoro)alkyl, where A and N are bonded to the phenyl ring of the benzoylguanidine parent structure; or R(2) is -SR(40), -OR(40), -NHR(40)R(41), -CHR(40)R(42), -C=CR(45) where R(40), R(41) are identical or different, and are -(CH2)p-(CHOH)q-(CH2)r-(CHOH)t-R(51) or -(CH2)p-O-(CH2-CH2O)q-R(51), R(51) is hydrogen or methyl, R(42), R(43) are hydrogen or alkyl or, together with the carbon atom carrying them, form a (C3-C8)-cycloalkyl; R(44) is H, (C1-C6)-alkyl, (C3-C8)-cycloalkyl, -CeH2e-R(45) where R(45) is phenyl, heteroaryl or alkyl, R(46), R(47), R(48), R(49) and R(50) are hydrogen or methyl; or R(2) is R(55)-NH-SO2-, R(3), R(4) and R(5) are independently of one another defined as R(1) or R(2); and their pharmaceutically tolerable salts.0
-
公开(公告)号:AT181322T
公开(公告)日:1999-07-15
申请号:AT94108280
申请日:1994-05-30
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A61K31/165 , A61K31/155 , A61K31/166 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/4418 , A61P9/00 , A61P9/06 , A61P9/10 , A61P43/00 , C07C277/08 , C07C279/22 , C07C311/15 , C07C317/32 , C07C317/44 , C07C317/48 , C07C323/62 , C07D207/337 , C07D213/30 , C07D213/53 , C07D213/54 , C07D213/58 , C07D213/65 , C07D215/14 , C07D217/16 , C07D231/12 , C07D233/06 , C07D233/61 , C07D233/64 , C07D241/26 , C07D241/28
Abstract: There are described benzoylguanidines of the formula I in which: R(1) is R(6)-CO or R(7)R(8)N-CO, where R(6), R(7) and R(8) are (perfluoro)alk(en)yl, -(CH)2n-R(9), R(9) is cycloalkyl, phenyl, biphenylyl or naphthyl, where R(7) and R(8) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; R(2) is defined as R(1), or is H, Hal, CN, NO2, (perfluoro)alk(en)yl, -(CH)2 R(15) where R(15) is cycloalkyl, phenyl, biphenylyl or naphthyl, or R(2) is (C1-C9)-heteroaryl, or R(2) is SR(18), -OR(18), -NR(18)R(19), -CR(18)R(19)R(20); R(18) = -(CH2)-heteroaryl, R(19), R(20) are defined as R(18) or are H, (perfluoro)-alkyl, or R(2) is R(21)-SOm or R(22)R(23)N-SO2-, where R(21) is (perfluoro)alk(en)yl, -CH2-R(24), R(24) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(22) is H, (perfluoro)alk(en)yl, -(CH2)n-R(29), R(29) is (C3-C8)-cycloalkyl, phenyl, biphenylyl or naphthyl, R(23) is H, (perfluoro)alkyl, where R(22) and R(23) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; or R(33)X-, where R(2) is X is oxygen, S, NR(34), (D=O)A-, NR(34)C=MN R(35)-, where M is oxygen, S, A = oxygen, NR(34), D = C, SO R(33) and R(35) are (perfluoro)alk(en)yl, -(CH2)n-R(36), where R(36) is cycloalkyl, phenyl, biphenylyl or naphthyl, R(34) = H, (perfluoro)alkyl, where A and N are bonded to the phenyl ring of the benzoylguanidine parent structure; or R(2) is -SR(40), -OR(40), -NHR(40)R(41), -CHR(40)R(42), -C=CR(45) where R(40), R(41) are identical or different, and are -(CH2)p-(CHOH)q-(CH2)r-(CHOH)t-R(51) or -(CH2)p-O-(CH2-CH2O)q-R(51), R(51) is hydrogen or methyl, R(42), R(43) are hydrogen or alkyl or, together with the carbon atom carrying them, form a (C3-C8)-cycloalkyl; R(44) is H, (C1-C6)-alkyl, (C3-C8)-cycloalkyl, -CeH2e-R(45) where R(45) is phenyl, heteroaryl or alkyl, R(46), R(47), R(48), R(49) and R(50) are hydrogen or methyl; or R(2) is R(55)-NH-SO2-, R(3), R(4) and R(5) are independently of one another defined as R(1) or R(2); and their pharmaceutically tolerable salts.0
-
公开(公告)号:ES2130472T3
公开(公告)日:1999-07-01
申请号:ES95109203
申请日:1995-06-14
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A61K31/165 , A01N1/02 , A61K31/16 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P31/04 , A61P35/00 , A61P37/08 , C07C277/08 , C07C279/22
Abstract: Perfluoroalkyl-substd. phenylalkenoyl-guanidine derivs. of formula (I) and their salts are new. Ra and Rb=H, halogen, CN, OH, OR6, 1-8C alkyl, Or(CH2)aRf, 3-8C cycloalkyl or NR7R8; r=0 or 1; a=0-4; Rf=1-8C perfluoroalkyl; R6=1-8C alkyl, 1-4C perfluoroalkyl, 3-8C alkenyl, 3-8C cycloalkyl, or phenyl or benzyl ring-substd. by 0-3 of F, Cl, CF3, Me, OMe and NR9R10; R9 and R10=H, 1-4C alkyl or 1-4C perfluoroalkyl; R7 and R8=gps. as defined for R6, or R7+R8=4 or 5 CH2 gps., one of which is opt. replaced by O, S, NH, NMe or NCH2Ph; x and y=0-2; Rc and Rd=H, halogen, CN, OR6, 1-8C alkyl, Or(CH2)aRf or 3-8C cycloalkyl; R1-R5=H, 1-8C alkyl, Or(CH2)aRf, 3-8C cycloalkyl, halogen or CN; provided that at least one of Ra, Rb, Rc, Rd, R1, R2, R4 and R5 is Or(CH2)aRf, and that R3 is not Or(CH2)aRf.
-
公开(公告)号:DE59505412D1
公开(公告)日:1999-04-29
申请号:DE59505412
申请日:1995-06-14
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A61K31/165 , A01N1/02 , A61K31/16 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P31/04 , A61P35/00 , A61P37/08 , C07C277/08 , C07C279/22
Abstract: Perfluoroalkyl-substd. phenylalkenoyl-guanidine derivs. of formula (I) and their salts are new. Ra and Rb=H, halogen, CN, OH, OR6, 1-8C alkyl, Or(CH2)aRf, 3-8C cycloalkyl or NR7R8; r=0 or 1; a=0-4; Rf=1-8C perfluoroalkyl; R6=1-8C alkyl, 1-4C perfluoroalkyl, 3-8C alkenyl, 3-8C cycloalkyl, or phenyl or benzyl ring-substd. by 0-3 of F, Cl, CF3, Me, OMe and NR9R10; R9 and R10=H, 1-4C alkyl or 1-4C perfluoroalkyl; R7 and R8=gps. as defined for R6, or R7+R8=4 or 5 CH2 gps., one of which is opt. replaced by O, S, NH, NMe or NCH2Ph; x and y=0-2; Rc and Rd=H, halogen, CN, OR6, 1-8C alkyl, Or(CH2)aRf or 3-8C cycloalkyl; R1-R5=H, 1-8C alkyl, Or(CH2)aRf, 3-8C cycloalkyl, halogen or CN; provided that at least one of Ra, Rb, Rc, Rd, R1, R2, R4 and R5 is Or(CH2)aRf, and that R3 is not Or(CH2)aRf.
-
-
-
-
-
-
-
-
-